GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ontrak Inc (NAS:OTRK) » Definitions » EPS (Diluted)

Ontrak (Ontrak) EPS (Diluted) : $-3.93 (TTM As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Ontrak EPS (Diluted)?

Ontrak's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $-0.11. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.93.

Ontrak's EPS (Basic) for the three months ended in Mar. 2024 was $-0.11. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.93.

Ontrak's EPS without NRI for the three months ended in Mar. 2024 was $-0.11. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-11.91.

During the past 3 years, the average EPS without NRIGrowth Rate was 27.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 1.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 5.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Ontrak's highest 3-Year average EPS without NRI Growth Rate was 82.00% per year. The lowest was -352.60% per year. And the median was 16.40% per year.


Ontrak EPS (Diluted) Historical Data

The historical data trend for Ontrak's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ontrak EPS (Diluted) Chart

Ontrak Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.36 -8.64 -14.82 -15.61 -3.30

Ontrak Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.26 -1.84 -1.76 -0.22 -0.11

Competitive Comparison of Ontrak's EPS (Diluted)

For the Health Information Services subindustry, Ontrak's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ontrak's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ontrak's PE Ratio distribution charts can be found below:

* The bar in red indicates where Ontrak's PE Ratio falls into.



Ontrak EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Ontrak's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-27.92-8.954)/11.159
=-3.30

Ontrak's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-4.458-2.239)/60.882
=-0.11

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ontrak  (NAS:OTRK) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Ontrak EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Ontrak's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Ontrak (Ontrak) Business Description

Traded in Other Exchanges
Address
2200 Paseo Verde Parkway, Suite 280, Henderson, NV, USA, 89052
Ontrak Inc is an AI and telehealth-enabled, virtualized outpatient healthcare treatment company. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The company's technology-enabled platform provides claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized treatment program.
Executives
Judith Feld officer: Chief Medical Officer 2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James M. Messina director 2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
Arik Hill officer: Chief Information Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Robert Accordino officer: Chief Medical Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Mary Louise Osborne officer: Chief Customer Officer 2200 PASEO VERDE PARKWAY, SUITE 280, HENDERSON NV 89052
James J Park officer: Chief Accounting Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Jonathan E. Mayhew officer: Chief Executive Officer ONE CVS DRIVE, WOONSOCKET RI 02895
Terren S Peizer director, 10 percent owner, officer: CEO 11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025
Robert I Newton officer: General Counsel and Secretary 1940 E. MARIPOSA AVE, ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
Katherine B Quinn director US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402
Robert Rebak director 2120 COLORADO BLVD., SUITE 230, SANTA MONICA CA 90404
Curtis Medeiros officer: Chief Operating Officer 2120 COLORADO AVE., SUITE 230, SANTA MONICA CA 90404
Brandon H Laverne officer: Chief Financial Officer 1940 E. MARIPOSA AVE., ATTN: BRANDON LAVERNE, EL SEGUNDO CA 90245
David E Smith 10 percent owner 888 LINDA FLORA DRIVE, LOS ANGELES CA 90049
Gustavo A Giraldo director 2120 COLORADO AVENUE, SUITE 230, SANTA MONICA CA 90404